Patent ID: 11911509
Assignee: SYNTHON B.V.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 5:
6. A pharmaceutical composition according to claim 1, comprising, based on the total weight of the composition,
a) a therapeutically effective dose of lenvatinib mesylate in an amount of from 4% to 25% by weight;
b) microcrystalline cellulose in an amount of from 20% to 65% by weight;
c) sodium bicarbonate in an amount of from 20 to 50%;
d) optionally, low substituted hydroxypropyl cellulose in an amount of from 15% to 25% by weight;
e) mannitol in an amount of from 7% to 18% by weight; and
f) talc in an amount of from 1% to 5% by weight.